Superluminal Medicines Inc. has closed an oversubscribed $60 million series B financing as it advances its pipeline of ...

Thryv Therapeutics Inc. has licensed a new class of SGK1 inhibitors from Spain’s Consejo Superior de Investigaciones ...

Although the supply of U.S. FDA-approved estradiol transdermal patches nearly doubled over the past year, the brand and ...

Researchers from Anlong Biopharmaceutical Co. Ltd. and collaborators reported preclinical efficacy data for AL-001, an ...

Artios Pharma Ltd. has synthesized antibody-drug conjugates (ADCs) comprising a monoclonal antibody linked to poly(ADP-ribose ...

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) is joining the EMA in withdrawing Amgen Inc.’s Tavneos ...

GSK plc is moving further into antibody-drug conjugates, taking ex-China rights to Hutchmed Ltd.’s HMPL-A830 in a deal worth ...

Sensorion SA has received authorization from the French agency ANSM to initiate a phase I/II trial of SENS-601 (GJB2-GT), the ...

Tscan Therapeutics Inc. has announced a strategic reorganization to prioritize its in vivo solid tumor program, with the ...

How to get additional patients diagnosed and hit the estimated peak sales of $100 million for Zanvastro (zilganersen) became ...

Foundation has announced IND clearance by the FDA for the first ever U.S. clinical trial of an experimental gene therapy for ...

Ionis Pharmaceuticals Inc. secured U.S. FDA approval the antisense drug for Zanvastro (zilganersen) to treat Alexander ...